MOESM1 of Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants

Additional file 1: Table S1. Dataset (A-cell epitopes and non-epitope) used for training, testing and validation; including source of information. Table S2. The percent amino acid composition and difference in composition for A-cell epitopes, non-epitopes and human proteins including Students t-test with p-value and adjusted p-value. Table S3. The percent dipeptide composition and difference in composition in A-cell epitopes, non-epitopes and human proteins. Table S4. The percent tripeptide compositions of A-cell epitopes, non-epitopes and human proteins. Rows are sorted in decreasing order of values in the 5th column. Table S5. Motifs exclusively found in A-cell epitopes and their frequency of occurrence, sorted in the decreasing order of counts. Table S6. Motifs exclusively found in non-epitopes and their frequency of occurrence, sorted in decreasing order of counts. Table S7. Performance of various classifiers on the trainingâ testing dataset and the independent dataset. Table S8. The performance of SVM-based A-cell epitope prediction models developed using various features; models were evaluating on training and independent datasets using fivefold cross-validation.